Search for: "CEPHALON, INC" Results 1 - 20 of 115
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 May 2018, 8:09 pm by Kurt R. Karst
Hull — Last week, the Superior Court of Pennsylvania struck a blow to Appellant Joseph Caltagirone’s wrongful death and survival claims against drug manufacturers Cephalon, Inc. and Teva Pharmaceuticals, USA, Inc. [read post]
11 Jan 2018, 5:00 am by melissalafreniere
Drug manufacturers and distributors hit with opioid lawsuits include: Purdue Teva/Cephalon Janssen Endo Actavis Mallinckrodt McKesson Corporation AmerisourceBergen Corporation Cardinal Health Inc. [read post]
30 Nov 2017, 8:59 pm by Brenda Fulmer
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
11 Apr 2016, 2:32 pm by Robert Reznick
  The FTC’s complaint attacks two such settlements that Endo Pharmaceuticals Inc. and the Japan-based patent holder for one of the relevant patents reached with generic manufacturers Watson Laboratories (and Watson’s current owner, Allergan plc) and Impax Laboratories, to settle Hatch-Waxman litigation involving Endo’s two most important products—the pain relievers Opana ER® and Lidoderm®.[2]  The FTC’s complaint, and its simultaneous… [read post]
8 Dec 2015, 2:22 pm by Ben Vernia
  AstraZeneca LP and Cephalon Inc. paid the United States $26.7 million and $4.3 million, respectively, in separate settlements for allegedly underpaying rebates owed under the Medicaid Drug Rebate Program. [read post]